FDA approves pancreatic cancer drug that extends patients’ lives – The Washington Post

FDA approves pancreatic cancer drug that extends patients’ lives  The Washington Publish F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer  The New York Occasions University of Cincinnati Cancer Center helps develop landmark pancreatic cancer drug  WLWT FDA approves once-daily pill for deadly cancer after patients’ survival rates nearly double  Fox Information FDA approves breakthrough drug daraxonrasib... Read More